Mary J. Kuhn is Executive VP & Operations at Talecris Biotherapeutics Holdings Corp. (TLCR). They have made 1 open-market trade across 1 company since 2010, most recently 2011-06-01.
CIK 0001472044
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| TLCR | 63,779 | — |
Shares reported on the most recent Form 4, priced at the 2011-04-05 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| TLCR | SELL · 10b5-1 | 2011-02-01 | 2011-02-02 | $24.36 | $1.3M | N/A | N/A | N/A |
| TLCR | SELL · 10b5-1 | 2011-01-03 | 2011-01-04 | $23.08 | $1.3M | N/A | N/A | N/A |
| TLCR | SELL · 10b5-1 | 2010-11-01 | 2010-11-02 | $24.37 | $1.1M | N/A | N/A | N/A |
| TLCR | SELL · 10b5-1 | 2010-10-01 | 2010-10-04 | $22.84 | $1.1M | N/A | N/A | N/A |
| TLCR | SELL | 2010-09-14 | 2010-09-16 | $23.01 | $759K | N/A | N/A | N/A |
| TLCR | SELL · 10b5-1 | 2010-09-01 | 2010-09-03 | $21.99 | $1.0M | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.